Quantitative analysis of survivin mrna expression in bladder transitional cell carcinomas

Acta Urologica Japonica

Volumn 54, Issue 2, 2008, Pages 101-106

  Kitsukawa, Shin Ichi ^a   Aoyagi, Teiichiro ^a   Noda, Kenjiro ^b   Ito, Takaaki ^b   Yamamoto, Yutaka ^b   Hosoda, Satoru ^b   Otsuru, Norihiko ^b   Matsumoto, Tetsuo ^b  

^a Tokyo Medical University Ibaraki Medical Center

^b TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

Author keywords

Bladder neoplasms; Survivin; Urine

Indexed keywords

BIRC5 PROTEIN, HUMAN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CHEMISTRY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; URINARY BLADDER NEOPLASMS;

EID: 40949116393     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921, 1997
2. Johnson AL, Langer JS and Bridgham JT: Survivin as a cell cycle-related and antiapoptotic protein in granulosa cells. Endocrinology 143: 3405-3413, 2002
3. Tamm I, Wang Y, Sausville E, et al.: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315-5320, 1998
4. Conway EM, Pollefeyt S, Steiner-Mosonyi M, et al.: Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology 123: 619-631, 2002
5. Xu AG, Li SG, Liu JH, et al.: Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroentero 7: 403-406, 2001
6. Shan CM and Li J: Study of apoptosis in human liver cancers. World J Gastroentero 8: 247-252, 2002
7. Zhang Z, Yuan Y, Gao H, et al.: Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroentero 7: 779-782, 2001
8. Ikeguchi M and Kaibara N: Survivin messenger RNA expression is a good prognostic biomarker for oecsophageal carcinoma. Br J Cancer 87: 883-887, 2002
9. Chakravarti A, Noll E, Black PM, et al.: Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20: 1063-1068, 2002
10. Swana HS, Grossman D, Anthony JN, et al.: Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341: 452-453, 1999
11. Weikert S, Christoph F, Schrader M, et al.: Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 116: 100-104, 2005
12. Ku JH, Kwak C, Lee HS, et al.: Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol 171: 631-635, 2004
13. Schultz IJ, Kiemeney LA, Witjes JA, et al.: Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res 23: 3327-3331, 2003
14. Altieri DC: Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22: 8581-8589, 2003
15. Williams NS, Gaynor RB, Scoggin S, et al.: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9: 931-946, 2003
16. Tanaka K, Iwamoto S, Gon G, et al.: Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6: 127-134, 2000